Influence of pigment epithelial detachment on visual acuity in neovascular age-related macular degeneration

Surv Ophthalmol. 2021 Jan-Feb;66(1):68-97. doi: 10.1016/j.survophthal.2020.05.003. Epub 2020 May 16.

Abstract

Pigment epithelial detachment (PED), the anatomical separation of the retinal pigment epithelium from the Bruch membrane, is common in many chorioretinal diseases, including neovascular age-related macular degeneration. PED is present in about 30% to 80% of neovascular age-related macular degeneration patients based on the CATT, EXCITE, and VIEW studies. The influence of PED on visual acuity is controversial as a result of inconsistent results reported by various studies. With advances in imaging technologies, it is possible to evaluate not only the presence or absence of PED, but also detailed quantitative parameters, such as height, width, greatest linear diameter, area, volume, and reflectivity within the PED. We performed a comprehensive literature review to evaluate the relationship of PED with visual acuity. In summary, the presence or persistence of a PED may still be compatible with relatively good visual acuity. There is no strong evidence that the presence of a PED or aspects of its morphology has a significant impact on visual acuity. The presence of a PED may be predictive of the need for more regular treatment. More well-designed studies with standardized PED definitions and classifications are needed to evaluate the relationship between PED and visual acuity.

Keywords: aflibercept; age-related macular degeneration; anti-VEGF; bevacizumab; choroidal neovascularisation; neovascular age-related macular degeneration; pigment epithelial detachment(s); ranibizumab; vision; visual acuity.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Humans
  • Intravitreal Injections
  • Macular Degeneration* / complications
  • Macular Degeneration* / drug therapy
  • Ranibizumab / therapeutic use
  • Retinal Detachment* / diagnosis
  • Retinal Detachment* / etiology
  • Retinal Pigment Epithelium
  • Retrospective Studies
  • Tomography, Optical Coherence / methods
  • Visual Acuity

Substances

  • Angiogenesis Inhibitors
  • Ranibizumab